Copyright
©The Author(s) 2025.
World J Exp Med. Jun 20, 2025; 15(2): 100443
Published online Jun 20, 2025. doi: 10.5493/wjem.v15.i2.100443
Published online Jun 20, 2025. doi: 10.5493/wjem.v15.i2.100443
Table 2 Correlation between clinicopathologic features and insulin-like growth factor 1 receptor expression in gallbladder cancer
Feature | IGF1R-positive (n = 17) | IGF1R-negative (n = 17) | P value |
Sex | |||
Male | 6 | 10 | |
Female | 11 | 7 | 0.17 |
Chemotherapy | |||
Yes | 11 | 10 | |
No | 6 | 7 | 0.72 |
T stage | |||
T1/T2 | 8 | 10 | |
T3/T4 | 9 | 7 | 0.49 |
N stage | |||
Negative | 8 | 12 | |
Positive | 9 | 5 | 0.16 |
M stage | |||
Negative | 14 | 16 | |
Positive | 3 | 1 | 0.28 |
Clinical stage | |||
I/II | 6 | 10 | |
III/IV | 11 | 7 | 0.16 |
- Citation: Wang Q, Fan C, Tsujio G, Sakuma T, Maruo K, Yamamoto Y, Imanishi D, Kawabata K, Nishikubo H, Kanei S, Aoyama R, Kushiyama S, Ohira M, Yashiro M. Establishment and characterization of a new human gallbladder cancer cell line, OCUG-2. World J Exp Med 2025; 15(2): 100443
- URL: https://www.wjgnet.com/2220-315x/full/v15/i2/100443.htm
- DOI: https://dx.doi.org/10.5493/wjem.v15.i2.100443